What does Celcuity Inc. do?
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and…
What is Celcuity Inc.'s P/E and P/B ratio?
Celcuity Inc. has a P/E ratio of -15.2 and a P/B ratio of -251.03.
What is Celcuity Inc.'s debt-to-equity ratio?
Celcuity Inc. has a debt-to-equity ratio of 3.20.
How much does Celcuity Inc. owe compared with what it owns?
Celcuity Inc. owes $1.02 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Celcuity Inc.'s Positivity rank?
Celcuity Inc. is ranked #6,742 of 6,774 companies globally and #3,972 of 4,000 in United States on PositoAI, with a Positivity Score of -146,495.
Does Celcuity Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Celcuity Inc..
Where can I read the latest news about Celcuity Inc.?
Recent headlines about Celcuity Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Celcuity Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Celcuity Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.